What is Natco Pharma Ltd (NATCOPHARM) share price today?

Natco Pharma Ltd (NATCOPHARM) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/NATCOPHARM for the latest live price, technical analysis, and AI-powered insights.

How to analyse NATCOPHARM stock?

VestAI provides comprehensive NATCOPHARM stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Natco Pharma Ltd in?

Natco Pharma Ltd (NATCOPHARM) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Natco Pharma Ltd

Q: What is Natco Pharma Ltd's Orion Score?

Natco Pharma Ltd has an Orion Score of 80/100 (Quality) — a fundamentals-based quality & risk score. Natco Pharma Ltd scores 80/100 (Quality) on the Orion Score — strong business quality (76), strong growth (79), strong balance-sheet safety (86) and cheap valuation (83). A fundamentals-based quality & risk score, not a buy/sell recommendation.

NATCOPHARM

NSE· Healthcare

₹979.95

-4.15 (-0.42%)

Updated 12:39 pm IST

52W Low · ₹789.0052W High · ₹1,226.80

Mid Range

Market Cap

₹16001.68L Cr

Volume

5.72L

Prev Close

₹984.10

ISIN

INE987B01026

Orion Score

Fundamentals-based quality & risk · not a recommendation

80/100

Quality

Natco Pharma Ltd scores 80/100 (Quality) on the Orion Score — strong business quality (76), strong growth (79), strong balance-sheet safety (86) and cheap valuation (83). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.0× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(10.05)Beneish M Clean(-3.05)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

48/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.08x — lean balance sheet

QUALITY

Average

ROCE 13.1% — decent returns

MOMENTUM

Neutral

RSI 50.8 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 11.27
ROCE: 13.09%
ROE (1Y): 16.85%
D/E Ratio: 0.08x
OPM: 10.45%
TTM EPS: ₹79.24
Dividend Yield: 73.00%
Qtrly Sales: ₹739.10 Cr
Qtrly Profit: ₹267.90 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹739.1	₹267.9	10.4%	₹14.96
Q3 2026	₹647.3	₹151.5	17.4%	₹8.46
Q2 2026	₹1,363	₹518.4	38.6%	₹28.94
Q1 2026	₹1,328.9	₹480.7	38.6%	₹26.84
Q4 2025	₹1,221	₹406.6	36.8%	₹22.70

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹4,078.3	₹1,418.5	₹1,734.1	30.2%
FY 2025	₹4,429.5	₹1,885.4	₹2,550.5	44.3%
FY 2024	₹3,978.8	₹1,388.3	₹1,872.3	39.6%
FY 2023	₹2,696.9	₹715.3	₹1,035.2	29.3%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
NATCOPHARM ★	₹16,002 Cr	11.27	13.09%	16.85%	0.08x	10.45%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹8,630.8	₹6,906.3	₹5,657.4	₹5,109.1
Equity	₹7,607	₹5,853.1	₹4,873.8	₹4,263.6
Total Debt	₹279.4	₹371.2	₹176.1	₹432
Cash	₹120	₹70.4	₹131.9	₹111.1
Net Debt	₹153.1	₹292.8	₹42.5	₹309.4
Working Capital	₹4,326.5	₹3,050.7	₹2,317.2	₹1,776.3

Shareholding Pattern

Q1 FY2027

Promoter

50.55%

FII

6.25%

DII

5.12%

Public

38.08%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	50.55% ↑	6.25% ↓	5.12% ↓	38.08% ↑
Q3 FY2026	49.48%	15.16% ↑	5.39% ↓	29.97% ↓
Q2 FY2026	49.48% ↓	14.09% ↓	5.87% ↑	30.56% ↑
Q1 FY2026	49.56%	15.52% ↓	5.81% ↑	29.12% ↑
Q4 FY2025	49.56% ↓	17.49% ↓	5.64% ↑	27.3% ↑
Q3 FY2025	49.62%	17.94% ↑	5.59% ↓	26.88% ↑
Q2 FY2025	49.62% ↓	17.51% ↑	6.75% ↓	26.13% ↑
Q1 FY2025	49.71%	17.45%	7.86%	24.99%

Corporate Actions

Ex-Date	Action	Details
2026-02-18	DIVIDEND	Interim Dividend - Rs 1.50 Per Share

Smart Money Holdings

Q3 FY2025

Investor	Shares Held	Portfolio %	Change
akash-bhanshali	18,00,788	1.00%	—

Funds Holding This Stock

54 mutual fund schemes

Samco Flexi Cap Fund Direct GrowthSamco MF

2.97%

₹8 Cr

Capitalmind Flexi Cap Fund Direct GrowthCapitalmind

2.32%

₹10 Cr

DSP Nifty Smallcap250 Quality 50 Index Fund Direct GrowthDSP

1.78%

₹6 Cr

The Wealth Company Flexi Cap Fund Direct GrowthThe Wealth Company

1.75%

₹4 Cr

Sundaram Small Cap Fund Direct GrowthSUNDARAM

1.58%

₹58 Cr

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

1.52%

₹3 Cr

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

1.51%

₹1 Cr

Samco Small Cap Fund Direct GrowthSamco MF

1.29%

₹2 Cr

Kotak Nifty Smallcap 50 Index Fund Direct GrowthKOTAK_MAHINDRA

1.23%

₹3 Cr

Axis Nifty Smallcap 50 Index Fund Direct GrowthAXIS

1.23%

₹8 Cr

Analyse NATCOPHARM with Orion AI

Ask: "Is Natco Pharma Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Natco Pharma Ltd (NATCOPHARM) Stock

Natco Pharma Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE987B01026. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.